Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com RELEASE FROM VOLUNTARY ESCROW 28 August 2026 – Melbourne, Australia ( 27 August 2026 – Minneapolis, MN United States)...
Release from Voluntary Escrow
Filed with ASX ·
6ix hasn’t read this filing yet.
Imricor Medical Systems, Inc. on 6ix
Earlier from Imricor Medical Systems
- Imricor and Philips Launch Commercial iMR Lab Solution
- Imricor U.S. Commercial Momentum Accelerates
- 1H 2026 Investor Presentation
- 2026 Q2 Form 10-Q
- Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission
Later from Imricor Medical Systems
- FDA Accepts Imricor PMA Manufacturing Module
- S&P DJI Announces September 2026 Quarterly Rebalance
- Application for quotation of securities - IMR
- Cleansing Notice
- FDA Completes Review of Third PMA Module
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems